BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9130006)

  • 1. Effects of Phytolacca acinosa polysaccharides I with different schedules on its antitumor efficiency in tumor bearing mice and production of IL-1, IL-2, IL-6, TNF, CSF activity in normal mice.
    Wang HB; Zheng QY
    Immunopharmacol Immunotoxicol; 1997 May; 19(2):197-213. PubMed ID: 9130006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of Phytolacca acinosa polysaccharide on splenic lymphocyte proliferation and cytokine secretion from splenic lymphocyte and macrophage].
    Wang HB; Zheng QY; Ju DW; Fang J
    Yao Xue Xue Bao; 1993; 28(10):732-7. PubMed ID: 8009984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of Phytolacca acinosa polysaccharides II on lymphocyte proliferation and colony stimulating factor production from mice splenocytes in vitro].
    Wang HB; Zheng QY; Ju DW; Fang J
    Yao Xue Xue Bao; 1993; 28(7):490-3. PubMed ID: 8285047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity and tumor necrosis factor production of Phytolacca acinosa polysaccharides I in mice.
    Zhang JP; Qian DH
    Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):542-5. PubMed ID: 8010055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of Phytolacca acinosa polysaccharides I on production of colony-stimulating factors of mouse splenocytes in vitro].
    Wang HB; Zheng QY; Chen HS
    Zhongguo Yao Li Xue Bao; 1993 Nov; 14 Suppl():S30-3. PubMed ID: 8010070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of Phytolacca acinosa polysaccharides I on cytotoxicity of macrophages and its production of tumor necrosis factor and interleukin 1].
    Zhang JP; Qian DH; Zheng QY
    Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):375-7. PubMed ID: 2104493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Phytolacca acinosa polysaccharides I on immune function in mice.
    Wang HB; Zheng QY; Qian DH; Fang J; Ju DW
    Zhongguo Yao Li Xue Bao; 1993 May; 14(3):243-6. PubMed ID: 8237401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Phytolacca acinosa polysaccharides I combined with interleukin-2 on the cytotoxicity of murine splenocytes against tumor cells.
    Wang HB; Chen WZ; Bao EJ; Zheng QY; Song HL; Fang J; Xu YX; Chen HS
    Yao Xue Xue Bao; 1995; 30(6):401-7. PubMed ID: 7572178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiating effect of granulocyte-macrophage colony-stimulating factor on interleukin-1-induced thymocyte proliferation: evidence for an interleukin-2 and tumor necrosis factor-independent pathway.
    Herbelin A; Machavoine F; Dy M
    Lymphokine Res; 1990; 9(2):155-65. PubMed ID: 2187117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.
    Matsumoto N; Aze Y; Akimoto A; Fujita T
    J Pharmacol Exp Ther; 1998 Jan; 284(1):189-95. PubMed ID: 9435177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential production of tumor necrosis factor, macrophage colony stimulating factor, and interleukin 1 by human alveolar macrophages.
    Becker S; Devlin RB; Haskill JS
    J Leukoc Biol; 1989 Apr; 45(4):353-61. PubMed ID: 2649630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of hepatic endothelial cell and macrophage proliferation and nitric oxide production by GM-CSF, M-CSF, and IL-1 beta following acute endotoxemia.
    Feder LS; Laskin DL
    J Leukoc Biol; 1994 Apr; 55(4):507-13. PubMed ID: 8145021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dependence of interleukin-1-induced arthritis on granulocyte-macrophage colony-stimulating factor.
    Yang YH; Hamilton JA
    Arthritis Rheum; 2001 Jan; 44(1):111-9. PubMed ID: 11212148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor on tumor necrosis factor and interleukin-1 production in human monocytes.
    Essner R; Rhoades K; McBride WH; Morton DL; Economou JS
    J Clin Lab Immunol; 1990 Aug; 32(4):161-6. PubMed ID: 1966932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.
    Yamamoto N; Zou JP; Li XF; Takenaka H; Noda S; Fujii T; Ono S; Kobayashi Y; Mukaida N; Matsushima K
    J Immunol; 1995 Mar; 154(5):2281-90. PubMed ID: 7868900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine-producing cell-stimulating activity. Interleukin 3 and granulocyte-macrophage colony-stimulating factor induce de novo synthesis of histidine decarboxylase in hemopoietic progenitor cells.
    Schneider E; Pollard H; Lepault F; Guy-Grand D; Minkowski M; Dy M
    J Immunol; 1987 Dec; 139(11):3710-7. PubMed ID: 2824613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent regulation of granulocyte-macrophage colony-stimulating factor and multi-lineage colony-stimulating factor production in T lymphocyte clones.
    Kelso A; Metcalf D; Gough NM
    J Immunol; 1986 Mar; 136(5):1718-25. PubMed ID: 3512707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective production of interleukin 3 (IL3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in vitro by murine L3T4+ T cells: lack of spontaneous IL3 and GM-CSF production by Ly-2-/L3T4- lpr subset.
    Davignon JL; Kimoto M; Kindler V; De Kossodo S; Vassalli P; Izui S
    Eur J Immunol; 1988 Sep; 18(9):1367-72. PubMed ID: 3139430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of colony-stimulating factor-1 in macrophage activation in tumor-bearing mice.
    Sakata T; Iwagami S; Tsuruta Y; Teraoka H; Suzuki S; Suzuki R
    J Immunol; 1992 Dec; 149(12):4002-8. PubMed ID: 1281198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
    Kinoshita Y; Kono T; Yasumoto R; Kishimoto T; Wang CY; Haas GP; Nishisaka N
    J Immunother; 2001; 24(3):205-11. PubMed ID: 11394497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.